The control of chemotherapy-induced emesis.

Nausea and vomiting are frequent and serious toxicities of cancer chemotherapy that have been largely ignored in the past. Recently there has been renewed interest in this significant problem, with important advances in understanding the physiology of vomiting and a burgeoning number of clinical trials that use newer classes of antiemetics. At present phenothiazines are the only class of antiemetics that have shown both efficacy and safety in large numbers of cancer patients, but they are inadequate against strongly emetic agents such as cisplatin. New agents and new approaches have shown promise but need additional testing before they can be recommended for routine use.
AuthorsL J Seigel, D L Longo
JournalAnnals of internal medicine (Ann Intern Med) Vol. 95 Issue 3 Pg. 352-9 (Sep 1981) ISSN: 0003-4819 [Print] UNITED STATES
PMID7023313 (Publication Type: Journal Article, Review)
Chemical References
  • Antiemetics
  • Antineoplastic Agents
  • Phenothiazines
  • Antiemetics (classification, pharmacology)
  • Antineoplastic Agents (adverse effects, pharmacology)
  • Humans
  • Medulla Oblongata (drug effects)
  • Phenothiazines (pharmacology)
  • Vomiting (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: